Bayer Consolidates Next-Generation Gene Editing Focus With Mammoth Deal

Pays $40m

 
• By Ayisha Sharma
  
Genetic Engineering, Scientist viewing cells in a culture jar with a DNA profiles on a screen in the background illustrating gene editing
Bayer Will Gain Access To Mammoth’s Ultra-Small Cas enzymes. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business